These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5877879)

  • 1. [Research on active immunity of man in bacillary dysentery. 3. Maintenance of the non-pathogenic character of the Shigella flexneri 2a TXXXII strain orally administered to volunteers].
    Istrati G; Meitert T; Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):677-86. PubMed ID: 5877879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antidysenteric vaccination. XIV. Immunizing action on the guinea pig conjunctiva of various toxic extracts of pathogenic Shigella flexneri 2a TI, as compared with that of live cultures of two non-pathogenic strains of Shigella flexneri 2a].
    Istrati M; Istrati G
    Arch Roum Pathol Exp Microbiol; 1966 Mar; 25(1):55-64. PubMed ID: 5973711
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live-attenuated Shigella vaccines.
    Venkatesan MM; Ranallo RT
    Expert Rev Vaccines; 2006 Oct; 5(5):669-86. PubMed ID: 17181440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-dysentery vaccination. X. Conjunctival vaccination of guinea pigs with non-pathogenic live Sh. flexneri 2a dysenteric bacilli].
    Istrati G; Istrati M
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):289-98. PubMed ID: 5877471
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antidysentery vaccination. XI. a. Pathogenic action on the guinea pig intestine following the administration "per os" of Shigella flexneri 2a strains (pathogenic and non-pathogenic for guinea pig conjunctiva). b. Attempted immunization by oral route as compared to the intraperitoneal route].
    Istrati G; Istrati M
    Arch Roum Pathol Exp Microbiol; 1964 Sep; 23(3):721-30. PubMed ID: 5318791
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-dysentery vaccination. 13. Immunogenicity of Sh. flexneri 2A as compared with the immunogenicity of a keratoconjunctivitis-positive enterobacterium devoid of Shigella antigens. Preliminary note].
    Ciufeco C; Grigoresco E; Istrati G
    Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):669-76. PubMed ID: 5877878
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on vaccination against bacillary dysentery. 2. Safety tests and reactogenicity studies on a live dysentery vaccine intended for use in field trials.
    Mel DM; Papo RG; Terzin AL; Vuksić L
    Bull World Health Organ; 1965; 32(5):637-45. PubMed ID: 5294179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of man to virulent Shigella flexneri 2a.
    DuPont HL; Hornick RB; Dawkins AT; Snyder MJ; Formal SB
    J Infect Dis; 1969 Mar; 119(3):296-9. PubMed ID: 5780532
    [No Abstract]   [Full Text] [Related]  

  • 12. Shigellosis in cynomolgus monkeys (Macaca irus). V. Resistance acquired by the repetition of experimental oral infection with Shigella flexneri 2A and fluctuation of serum agglutinin titer.
    Honjo S; Takasaka M; Fujiwara T; Kaneko M; Imaizumi K
    Jpn J Med Sci Biol; 1967 Aug; 20(4):341-8. PubMed ID: 4966140
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on Shigella vaccines.
    Ashkenazi S; Cohen D
    Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
    Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background.
    Roberts F; Jennison AV; Verma NK
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):285-9. PubMed ID: 15963704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of immunoprophylaxis and immunotherapy by live dysentery vaccine administration in children and adults collectivities.
    Meitert T; Ciudin L; Pencu E; Tonciu M; Gheorghe G
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):357-69. PubMed ID: 6763515
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
    Phalipon A; Sansonetti P
    Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to experimental mouse shigellosis.
    Rauss K; Kétyi I
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):491-6. PubMed ID: 5666686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.